Axcan Pharma Continues Solid Growth in Fiscal 2007, With Record Revenue of $85.3 Million in the Second Quarter

MONT-SAINT-HILAIRE, QUEBEC -- (MARKET WIRE) -- May 10, 2007 -- Axcan Pharma Inc. (TSX: AXP) (NASDAQ: AXCA) - Revenue of $85.3 Million, a 17.2% Increase Compared to the Second Quarter of Fiscal 2006.